Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study-Reference-Cited by-同舟云学术

Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study

Published:2023-04 Issue:4 Volume:86 Page:352-360
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Evans Andrew,Qi Cathy,Adebayo Jubril Omololu,Underwood Jonathan,Coulson James,Bailey Rowena,Lyons Ronan,Edwards Adrian,Cooper Alison,John Gareth,Akbari Ashley

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference33 articles.

1. Department of Health and Social Care. Government launches COVID-19 antivirals taskforce to roll out innovative home treatments this autumn; 2021 [cited 2023 Jan 20]. Available from: 〈https://www.gov.uk/government/news/government-launches-covid-19-antivirals-taskforce-to-roll-out-innovative-home-treatments-this-autumn〉.

2. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab;Gupta;N Engl J Med,2021

3. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients;Jayk Bernal;N Engl J Med,2022

4. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19;Hammond;N Engl J Med,2022

5. Early remdesivir to prevent progression to severe Covid-19 in outpatients;Gottlieb;N Engl J Med,2022

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study;Clinical Microbiology and Infection;2024-10

2. Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study;BMC Infectious Diseases;2024-09-03

3. Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity-matched retrospective cohort study of a pan-provincial program in Alberta, Canada;International Journal of Infectious Diseases;2024-09

4. A Real-World Retrospective Study on the Efficacy and Safety of Four Antiviral Drugs for Hospitalized COVID-19 Patients: Nirmatrelvir/Ritonavir, Simnotrelvir/Ritonavir, Molnupiravir and Azvudine;Infection and Drug Resistance;2024-09

5. Real-world effectiveness of molnupiravir, azvudine and paxlovid against mortality and viral clearance among hospitalized patients with COVID-19 infection during the omicron wave in China: A retrospective cohort study;Diagnostic Microbiology and Infectious Disease;2024-08